AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30

Authors: KAY NE LEONG T BONE N KYLE RA GREIPP PR VANNESS B OKEN MM
Citation: Ne. Kay et al., T-HELPER PHENOTYPES IN THE BLOOD OF MYELOMA PATIENTS ON ECOG PHASE-III TRIALS E9486 E3A93/, British Journal of Haematology, 100(3), 1998, pp. 459-463

Authors: GREIPP PR LEONG T BENNETT JM GAILLARD JP KLEIN B STEWART JA OKEN MM KAY NE VANNESS B KYLE RA
Citation: Pr. Greipp et al., PLASMABLASTIC MORPHOLOGY - AN INDEPENDENT PROGNOSTIC FACTOR WITH CLINICAL AND LABORATORY CORRELATES - EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) MYELOMA TRIAL E9486 REPORT BY THE ECOG MYELOMA LABORATORY GROUP, Blood, 91(7), 1998, pp. 2501-2507

Authors: BILLADEAU D PROSPER F VERFAILLIE C WEISDORF D VANNESS B
Citation: D. Billadeau et al., SEQUENTIAL-ANALYSIS OF BONE-MARROW AND PERIPHERAL-BLOOD AFTER STEM-CELL TRANSPLANT FOR MYELOMA SHOWS DISPARATE TUMOR INVOLVEMENT, Leukemia, 11(9), 1997, pp. 1565-1570

Authors: WENG WK SHAH N OBRIEN D VANNESS B LEBIEN TW
Citation: Wk. Weng et al., DIFFERENTIAL INDUCTION OF DNA-BINDING ACTIVITIES FOLLOWING CD19 CROSS-LINKING IN HUMAN B-LINEAGE CELLS, The Journal of immunology, 159(11), 1997, pp. 5502-5508

Authors: BILLADEAU D LIU PC JELINEK D SHAH N LEBIEN TW VANNESS B
Citation: D. Billadeau et al., ACTIVATING MUTATIONS IN THE N-RAS AND K-RAS ONCOGENES DIFFERENTIALLY AFFECT THE GROWTH-PROPERTIES OF THE IL-6-DEPENDENT MYELOMA CELL-LINE ANBL6, Cancer research, 57(11), 1997, pp. 2268-2275

Authors: KAY NE BONE N LEONG T OKEN MM KYLE RA VANNESS B GREIPP PR
Citation: Ne. Kay et al., SEQUENTIAL PHENOTYPIC ANALYSIS OF BLOOD IMMUNE CELLS IN MYELOMA PATIENTS TREATED ON ECOG PROTOCOL E9486 - RELATIONSHIP OF IMMUNE CELLS TO TREATMENT AND CLINICAL OUTCOME, Blood, 90(10), 1997, pp. 1595-1595

Authors: KAY NE LEONG T KYLE RA GREIPP P BILLADEAU D VANNESS B BONE N OKEN MM
Citation: Ne. Kay et al., CIRCULATING BLOOD B-CELLS IN MULTIPLE-MYELOMA - ANALYSIS AND RELATIONSHIP TO CIRCULATING CLONAL CELLS AND CLINICAL-PARAMETERS IN A COHORT OF PATIENTS ENTERED ON THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-IIIE9486 CLINICAL-TRIAL, Blood, 90(1), 1997, pp. 340-345

Authors: PRABHU A OBRIEN DP WEISNER GL FULTON R VANNESS B
Citation: A. Prabhu et al., OCTAMER INDEPENDENT ACTIVATION OF TRANSCRIPTION FROM THE KAPPA-IMMUNOGLOBULIN GERMLINE PROMOTER, Nucleic acids research, 24(23), 1996, pp. 4805-4811

Authors: LIU PC LEONG T QUAM L BILLADEAU D KAY NE GREIPP P KYLE RA OKEN MM VANNESS B
Citation: Pc. Liu et al., ACTIVATING MUTATIONS OF N-RAS AND K-RAS IN MULTIPLE-MYELOMA SHOW DIFFERENT CLINICAL ASSOCIATIONS - ANALYSIS OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-III TRIAL, Blood, 88(7), 1996, pp. 2699-2706

Authors: LIU P VANNESS B
Citation: P. Liu et B. Vanness, DIFFERENTIAL EFFECT OF INTERFERON-ALPHA ON DEXAMETHASONE AND ALL-TRANS-RETINOIC ACID-INDUCED APOPTOSIS IN MYELOMA CELLS, Blood, 88(10), 1996, pp. 388-388

Authors: LIU P ROWLEY M VANNESS B
Citation: P. Liu et al., WILDTYPE RB AND P53 CAN SUPPRESS AUTOCRINE IL-6 PRODUCTION AND PROLIFERATION OF U266 MYELOMA CELLS, Blood, 88(10), 1996, pp. 389-389

Authors: TRENDLE MC LEONG T KYLE RA OKEN MM KAY NE VANNESS B GREIPP PR
Citation: Mc. Trendle et al., HYPODIPLOID MYELOMA REVISITED - RESPONSE TO THERAPY AND SURVIVAL IN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY E9486, Blood, 88(10), 1996, pp. 1549-1549

Authors: KAY NE BONE N LEONG T OKEN MM KYLE RA VANNESS B GREIPP PR
Citation: Ne. Kay et al., T-HELPER PHENOTYPES IN THE BLOOD OF MYELOMA PATIENTS - ANALYSIS BY TREATMENT STATUS AND WITH CLINICAL-PARAMETERS, Blood, 88(10), 1996, pp. 1557-1557

Authors: BILLADEAU D VANNESS B KIMLINGER T KYLE RA THERNEAU TM GREIPP PR WITZIG TE
Citation: D. Billadeau et al., CLONAL CIRCULATING CELLS ARE COMMON IN PLASMA-CELL PROLIFERATIVE DISORDERS - A COMPARISON OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, SMOLDERING MULTIPLE-MYELOMA, AND ACTIVE MYELOMA, Blood, 88(1), 1996, pp. 289-296

Authors: KAY NE OKEN MM KYLE R VANNESS B KALISH L LEONG T GREIPP P
Citation: Ne. Kay et al., SEQUENTIAL PHENOTYPING OF MYELOMA PATIENTS ON CHEMOTHERAPY - PERSISTENCE OF ACTIVATED T-CELLS AND NATURAL-KILLER-CELLS, Leukemia & lymphoma, 16(3-4), 1995, pp. 351-354

Authors: WENG WK OBRIEN D VANNESS B LEBIEN TW
Citation: Wk. Weng et al., SIGNALING THROUGH CD19 ACTIVATES AP1 TRANSCRIPTION FACTORS IN HUMAN B-LINEAGE CELLS, The FASEB journal, 9(3), 1995, pp. 214-214

Authors: BILLADEAU D JELINEK DF SHAH N LEBIEN TW VANNESS B
Citation: D. Billadeau et al., INTRODUCTION OF AN ACTIVATED N-RAS ONCOGENE ALTERS THE GROWTH-CHARACTERISTICS OF THE INTERLEUKIN 6-DEPENDENT MYELOMA CELL-LINE ANBL6, Cancer research, 55(16), 1995, pp. 3640-3646

Authors: BILLADEAU D VANNESS B KIMLINGER T KYLE RA OFALLON WM GREIPP PR WITZIG TE
Citation: D. Billadeau et al., CLONAL CIRCULATING CELLS ARE A COMMON OCCURRENCE IN PLASMA-CELL DISORDERS - A COMPARISON OF MGUS, SMM AND MM, Blood, 86(10), 1995, pp. 218-218

Authors: KAY N LEONG T VANNESS B OKEN M GREIPP P BONE N BILLADEAU D KYLE R
Citation: N. Kay et al., CIRCULATING CD19-CELLS IN MULTIPLE-MYELOMA - PHENOTYPIC AND MOLECULARANALYSIS OF ECOG TRIAL E9486( BLOOD)9487/, Blood, 86(10), 1995, pp. 1088-1088

Authors: OKEN MM LEONG T KAY NE GREIPP PR VANNESS B KYLE RA
Citation: Mm. Oken et al., THE EFFECT OF ADDING INTERFERON (RIFN(ALPHA-2)) OR HIGH-DOSE CYCLOPHOSPHAMIDE TO VBMCP TO TREAT MULTIPLE-MYELOMA - RESULTS FROM AN ECOG PHASE-III TRIAL, Blood, 86(10), 1995, pp. 1749-1749

Authors: VANNESS B LEONG T QUAM L LIU P BILLADEAU D KAY N OKEN MM GREIPP P KYLE R
Citation: B. Vanness et al., DISTINCT RAS MUTATIONS IN MULTIPLE-MYELOMA (MM) CORRELATE WITH TUMOR BURDEN AND SURVIVAL - ANALYSIS OF ECOG PHASE-III TRIAL, Blood, 86(10), 1995, pp. 1755-1755

Authors: KAY NE OKEN MM BONE N KYLE RA GREIPP P VANNESS B LEONG T
Citation: Ne. Kay et al., CIRCULATING CD19(-CELL LEVELS IN MYELOMA() BLOOD), Blood, 86(10), 1995, pp. 4000-4000

Authors: OBRIEN DP BILLADEAU D VANNESS B
Citation: Dp. Obrien et al., RT-PCR ASSAY FOR DETECTION OF TRANSCRIPTS FROM VERY FEW CELLS USING WHOLE-CELL LYSATES, BioTechniques, 16(4), 1994, pp. 586

Authors: SCHANKE JT MARCUZZI A PODZORSKI RP VANNESS B
Citation: Jt. Schanke et al., AN AP1 BINDING-SITE UPSTREAM OF THE KAPPA-IMMUNOGLOBULIN INTRON ENHANCER BINDS INDUCIBLE FACTORS AND CONTRIBUTES TO EXPRESSION, Nucleic acids research, 22(24), 1994, pp. 5425-5432

Authors: FULTON R VANNESS B
Citation: R. Fulton et B. Vanness, SELECTIVE SYNERGY OF IMMUNOGLOBULIN ENHANCER ELEMENTS IN B-CELL DEVELOPMENT - A CHARACTERISTIC OF KAPPA-LIGHT-CHAIN ENHANCERS, BUT NOT HEAVY-CHAIN ENHANCERS, Nucleic acids research, 22(20), 1994, pp. 4216-4223
Risultati: 1-25 | 26-30